RTOG Foundation, Inc.
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
- Conditions
- Interventions
- First Posted Date
- 2004-02-12
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 77
- Registration Number
- NCT00006388
- Locations
- 🇺🇸
Valley Hospital, Ridgewood, New Jersey, United States
🇺🇸North Mississippi Medical Center/Cancer Center, Tupelo, Mississippi, United States
🇺🇸Emory University Hospital - Atlanta, Atlanta, Georgia, United States
Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2004-02-11
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 81
- Registration Number
- NCT00077064
- Locations
- 🇺🇸
Mount Carmel Health - West Hospital, Columbus, Ohio, United States
🇺🇸Doctors Hospital at Ohio Health, Columbus, Ohio, United States
🇺🇸Great Lakes Cancer Institute at McLaren Regional Medical Center, Flint, Michigan, United States
Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-01-29
- Last Posted Date
- 2013-11-03
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 64
- Registration Number
- NCT00005022
- Locations
- 🇺🇸
Northwest Community Hospital, Arlington Heights, Illinois, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-01-13
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 233
- Registration Number
- NCT00075868
- Locations
- 🇺🇸
Mercy Cancer Institute at Mercy Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
- Conditions
- First Posted Date
- 2003-12-31
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00006481
- Locations
- 🇺🇸
Sinai Hospital of Baltimore, Baltimore, Maryland, United States
🇺🇸MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States
🇺🇸Tulane University School of Medicine, New Orleans, Louisiana, United States
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
- First Posted Date
- 2003-11-26
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 243
- Registration Number
- NCT00003313
- Locations
- 🇺🇸
North Mississippi Medical Center/Cancer Center, Tupelo, Mississippi, United States
🇺🇸RMH Regional Canter Center, Harrisonburg, Virginia, United States
🇺🇸Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States
Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
- Conditions
- First Posted Date
- 2003-10-21
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00023738
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Harbor Hospital Center, Baltimore, Maryland, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
- Conditions
- First Posted Date
- 2003-10-15
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00023725
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 43
- Registration Number
- NCT00069953
- Locations
- 🇺🇸
Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
🇺🇸Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-09-30
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 84
- Registration Number
- NCT00003930
- Locations
- 🇺🇸
Sinai Hospital of Baltimore, Baltimore, Maryland, United States
🇺🇸Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸Huntsville Hospital System, Huntsville, Alabama, United States